![](/img/cover-not-exists.png)
Utility of a clinical risk score to identify high-risk patients with de novo acute myeloid leukaemia in first remission after high-dose cytarabine (HiDAC) based induction chemotherapy
Ling, Victoria, Burnett, Alan K., Bradstock, Ken, Seymour, John F., Hills, Robert K., Wei, AndrewVolume:
160
Language:
english
Journal:
British Journal of Haematology
DOI:
10.1111/bjh.12178
Date:
March, 2013
File:
PDF, 147 KB
english, 2013